The Antitrust Practice Group addresses public and private enforcement
activity and competition policy affecting all sectors of the health care
industry, including health care providers, health insurers, and medical device
and pharmaceutical companies. The Practice Group also maintains a discussion
list; publishes email alerts, member briefings, and executive summaries; and
sponsors webinars and in-person luncheons.